Multi-Omics Integrative and Functional Analysis of Glia Maturation Factor-γ: Associations with Malignant Phenotypes and Immune Microenvironment Features in Glioblastoma

Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults. Therapeutic outcomes are severely limited by temozolomide (TMZ) chemoresistance and the immunosuppressive tumor microenvironment (TME). Glia maturation factor-γ (GMFG) is linked to cytoskeletal and myeloid remodeling in other cancers, yet its roles in glioma remain poorly explored. We integrated multi-omics analyses to dissect GMFG expression, clinical associations, epigenetic mechanisms, and immune association. CCK-8, Celigo scratch, Transwell, and Annexin V-APC apoptosis assays were performed to elucidate the biological function of GMFG in GBM. GMFG was prioritized based on overlapping hypoxia, isocitrate dehydrogenase (IDH)-wildtype and TMZ-resistance gene signatures. GMFG was upregulated and correlated with adverse clinical features. GMFG knockdown suppressed the cell viability, migration, and invasion of GBM cells and increased Annexin V-APC positivity. GMFG genetic alterations were rare, and CpG hypomethylation across multiple regulatory regions correlated with transcriptional activation; the hypomethylated group showed higher mRNA expression. GMFG K74 acetylation was elevated in GBM and correlated with protein abundance. At single-cell resolution, Chemo_TAM dominated the GMFG-high myeloid population; CellChat predicted prominent signaling pathways underlying tumor–Chemo_TAM crosstalk. GMFG expression positively correlated with immunosuppressive markers and several immune checkpoint molecules; OncoPredict identified candidate drugs with lower predicted IC50 in GMFG-high tumors. Integrated bioinformatic analyses suggest that GMFG is associated with the malignant phenotype and immune microenvironment in glioma, as well as epigenetic alterations—hypomethylation and K74 acetylation. In vitro, GMFG promoted the viability, migration, and invasion of GBM cells, and reduced Annexin V-APC positivity.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-16
DOI
https://doi.org/10.3390/ijms272210288
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multi-Omics Integrative and Functional Analysis of Glia Maturation Factor-γ: Associations with Malignant Phenotypes and Immune Microenvironment Features in Glioblastoma

Hui Deng, Na Han, Mengxian Zhang, Qingya Qiu et al.
1 links
International Journal of Molecular Sciences
Glioma Diagnosis and Treatment
article

Multi-Omics Integrative and Functional Analysis of Glia Maturation Factor-γ: Associations with Malignant Phenotypes and Immune Microenvironment Features in Glioblastoma

Hui Deng, Na Han, Mengxian Zhang, Qingya Qiu, Jiarui Bu, Tingjun Zhang, Ping Song
article en

Abstract

Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults. Therapeutic outcomes are severely limited by temozolomide (TMZ) chemoresistance and the immunosuppressive tumor microenvironment (TME). Glia maturation factor-γ (GMFG) is linked to cytoskeletal and myeloid remodeling in other cancers, yet its roles in glioma remain poorly explored. We integrated multi-omics analyses to dissect GMFG expression, clinical associations, epigenetic mechanisms, and immune association. CCK-8, Celigo scratch, Transwell, and Annexin V-APC apoptosis assays were performed to elucidate the biological function of GMFG in GBM. GMFG was prioritized based on overlapping hypoxia, isocitrate dehydrogenase (IDH)-wildtype and TMZ-resistance gene signatures. GMFG was upregulated and correlated with adverse clinical features. GMFG knockdown suppressed the cell viability, migration, and invasion of GBM cells and increased Annexin V-APC positivity. GMFG genetic alterations were rare, and CpG hypomethylation across multiple regulatory regions correlated with transcriptional activation; the hypomethylated group showed higher mRNA expression. GMFG K74 acetylation was elevated in GBM and correlated with protein abundance. At single-cell resolution, Chemo_TAM dominated the GMFG-high myeloid population; CellChat predicted prominent signaling pathways underlying tumor–Chemo_TAM crosstalk. GMFG expression positively correlated with immunosuppressive markers and several immune checkpoint molecules; OncoPredict identified candidate drugs with lower predicted IC50 in GMFG-high tumors. Integrated bioinformatic analyses suggest that GMFG is associated with the malignant phenotype and immune microenvironment in glioma, as well as epigenetic alterations—hypomethylation and K74 acetylation. In vitro, GMFG promoted the viability, migration, and invasion of GBM cells, and reduced Annexin V-APC positivity.

International Journal of Molecular SciencesVol. 27(22)
Duke Kunshan University (CN), Tongji Hospital (CN), Huazhong University of Science and Technology (CN)
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon